Novel aggregate structure adjuvants modulate lymphocyte proliferation and Th1 and Th2 cytokine profiles in ovalbumin immunized mice

By Rajananthanan P.   Attard G.S.   Sheikh N.A.   Morrow W.J.W.  

Vaccine, Vol. 18, Iss. 1, 1999-08 ,pp. : 140-152

Elsevier

Access to resources Recommend Favorite

Induction of a cytotoxic T-cell response to HIV-1 proteins with short synthetic peptides and human compatible adjuvants

By Peter K.   Men Y.   Pantaleo G.   Gander B.   Corradin G.  

Vaccine, Vol. 19, Iss. 30, 2001-07 ,pp. : 4121-4129

Elsevier

Access to resources Recommend Favorite

Analysis of the ability of five adjuvants to enhance immune responses to a chimeric plant virus displaying an HIV-1 peptide

By McInerney T.L.   Brennan F.R.   Jones T.D.   Dimmock N.J.  

Vaccine, Vol. 17, Iss. 11, 1999-03 ,pp. : 1359-1368

Elsevier

Access to resources Recommend Favorite

Flt3 ligand and conjugation to IL-1 peptide as adjuvants for a type 1, T-cell response to an HIV p17 gag vaccine

By Pisarev V.M.   Parajuli P.   Mosley R.L.   Chavez J.   Zimmerman D.   Winship D.   Talmadge J.E.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2358-2368

Elsevier

Access to resources Recommend Favorite

Towards the design and operation of fire safe school facilities

By Hassanain Mohammad A.  

Disaster Prevention and Management: An International Journal, Vol. 15, Iss. 5, 2006-10 ,pp. : 838-846

Emerald Group Publishing Ltd

Access to resources Recommend Favorite